By Iain Gilbert
Date: Monday 18 Aug 2025
(Sharecast News) - Biotechnology firm Aptamer said on Monday that it has secured an extension and new work order with a "top five global pharma partner".
Aptamer stated that following the successful completion of a project for the development of Optimer binders to support an ELISA assay, it has now secured...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news